Treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma: A national perspective

Journal of the American College of Surgeons

Volumn 218, Issue 2, 2014, Pages 196-205

  Mayo, Skye C ^a   Mavros, Michael N ^a,c   Nathan, Hari ^d   Cosgrove, David ^a   Herman, Joseph M ^a   Kamel, Ihab ^a   Anders, Robert A ^b   Pawlik, Timothy M ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON HOSPITAL CENTER   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CHILD; FEMALE; FIBROLAMELLAR CARCINOMA; HEMIHEPATECTOMY; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PARTIAL HEPATECTOMY; POPULATION RESEARCH; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SCHOOL CHILD; TUMOR ABLATION; VERY ELDERLY; WEDGE RESECTION; YOUNG ADULT;

FIBROLAMELLAR CARCINOMA; FLC; HAZARD RATIO; HCC; HEPATOCELLULAR CARCINOMA; HR; NATIONAL CANCER INSTITUTE; NCI; OS; OVERALL SURVIVAL;

ADULT; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MORBIDITY; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL RATE; TIME FACTORS; UNITED STATES;

EID: 84892621781     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2013.10.011     Document Type: Article

References (24)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. H.B. El-Serag, and J.A. Davila Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study Hepatology 39 2004 798 803
3. F. Stipa, S.S. Yoon, and K.H. Liau et al. Outcome of patients with fibrolamellar hepatocellular carcinoma Cancer 106 2006 1331 1338
4. J.R. Craig, R.L. Peters, H.A. Edmondson, and M. Omata Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features Cancer 46 1980 372 379
5. D.M. Nagorney, M.A. Adson, and L.H. Weiland et al. Fibrolamellar hepatoma Am J Surg 149 1985 113 119
6. C.S. Ang, R.K. Kelley, and M.A. Choti et al. Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium Gastrointest Cancer Res 6 2013 3 9
7. B. Asiyanbola, D. Chang, and A.L. Gleisner et al. Operative mortality after hepatic resection: are literature-based rates broadly applicable? J Gastrointest Surg 12 2008 842 851
8. S.C. Mayo, A.D. Shore, and H. Nathan et al. Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion HPB (Oxford) 13 2011 473 482
9. V. Maniaci, B.R. Davidson, and K. Rolles et al. Fibrolamellar hepatocellular carcinoma: prolonged survival with multimodality therapy Eur J Surg Oncol 35 2009 617 621
10. B. Ringe, C. Wittekind, and A. Weimann et al. Results of hepatic resection and transplantation for fibrolamellar carcinoma Surg Gynecol Obstet 175 1992 299 305
11. National Cancer Institute D, Surveillance Research Program, Cancer Statistics Branch. Surveillance, Epidemiology, and End Results (SEER) program (http://www.seer.cancer.gov) SEER* Stat database: Incidence, SEER 17 regs public-use, Nov 2005 sub (1973-2003 varying), linked to county attributes, total U.S., 1969-2003 counties. Released April 2006, based on the November 2005 submission. Accessed November 7, 2013.
12. A.G. Fritz International Classification of Diseases for Oncology: ICD-O 3rd ed. 2000 World Health Organization Geneva
13. S.M. Strasberg The International Hepato-Pancreato-Biliary Association. The Brisbane: 2000 Terminology of Liver Anatomy and Resections HBP 2 2000 333 339
14. A. Agresti Introduction to categorical data analysis 1996 Wiley New York 182-185, 187-189, 201, 217, 279
15. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
16. D. Cox Regression models and life tables J R Stat Soc B 34 1972 187 220
17. D.W. Hosmer, and S. Lemeshow Applied Survival Analysis: Regression Modeling of Time to Event Data 2nd ed. 1999 John Wiley and Sons, Inc New York
18. D.W. Hosmer, and S. Lemeshow Applied Logistic Regression Second Edition 2000 John Wiley and Sons, Inc New York
19. S. Lemeshow, and D.W. Hosmer Jr. A review of goodness of fit statistics for use in the development of logistic regression models Am J Epidemiol 115 1982 92 106
20. T. Ichikawa, M.P. Federle, and L. Grazioli et al. Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases Radiology 213 1999 352 361
21. H.A. Edmondson Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood AMA J Dis Child 91 1956 168 186
22. T. Eggert, K.A. McGlynn, and A. Duffy et al. Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000-10 Gut 62 2013 1667 1668
23. M.N. Mavros, S.C. Mayo, O. Hyder, and T.M. Pawlik A systematic review: treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma J Am Coll Surg 215 2012 820 830
24. V.B. Weeda, M. Murawski, and A.J. McCabe et al. Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma - Results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience Eur J Cancer 49 2013 2698 2704